Sorted By:

Relevance


RxE HCV in Louisiana

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-louisiana

Four Facts: Value and Cost of Medicines

PhRMA  |  Blog Post

In the current marketplace, patients are required to pay more out of pocket for the medicines they need – to help manage disease and prevent complications – than for hospital and physician visits.
http://catalyst.phrma.org/four-facts-value-and-cost-of-medicines

New surveys find payers and providers want more data from biopharmaceutical companies

PhRMA  |  Blog Post

FDA has begun to acknowledge this and has started taking steps to facilitate communications between biopharmaceutical companies and other key health care stakeholders.
http://catalyst.phrma.org/new-surveys-find-payers-and-providers-want-more-data-from-biopharmaceutical-companies

Going boldly together: New advancements and new anniversaries

PhRMA  |  Blog Post

Each year we celebrated two birthdays – his real one on July 30 and his liver-versary on October 7.
http://catalyst.phrma.org/going-boldly-together-new-advancements-and-new-anniversaries

Human Immunodeficiency Virus (HIV)

Access Better Coverage  |  From Our Network

According to research on family budgets, he is likely to use a bit more than half of his income on necessities such as food, housing, taxes and transportation.
http://www.accessbettercoverage.org/patient/human-immunodeficiency-virus-hiv

Access to HIV/AIDS Medicines in Exchange Plans (2016)

PhRMA  |  Fact Sheet

This analysis provides insights into how plans in the health insurance exchanges and employer plans cover HIV/AIDS medicines.
https://www.phrma.org/fact-sheet/access-to-hiv/aids-medicines-in-exchange-plans-2016

RxE HCV in Florida

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-florida

Medicines have significantly increased chances of cancer survival around the globe

PhRMA  |  Blog Post

New treatments continue to alter the course of previously fatal diseases and there are now more promising cancer medicines in the pipeline than at any time in history.
http://catalyst.phrma.org/medicines-have-significantly-increased-chances-of-cancer-survival-around-the-globe

RxE HCV in Illinois

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-illinois

Guest Post: Johnson and Johnson is celebrating outstanding scientists: Who will be next?

PhRMA  |  Blog Post

Is there an exceptional researcher—perhaps one of your peers, colleagues or even a mentor—who has inspired you?
http://catalyst.phrma.org/guest-post-johnson-and-johnson-is-celebrating-outstanding-scientists-who-will-be-next

How innovative medicines are benefiting countries across the globe

PhRMA  |  Blog Post

What’s more is the profound impact that biopharmaceutical companies have on the global economy, including the creation of high-skill jobs, R&D investment, and medicines that improve worker productivity.
http://catalyst.phrma.org/how-innovative-medicines-are-benefiting-countries-across-the-globe

17 years (and more) of medical discoveries

PhRMA  |  Blog Post

Each and every one of these medical advancements has led me here, 17 years later, and science willing, many, many more.   
http://catalyst.phrma.org/17-years-and-more-of-medical-discoveries

Medicare Monday: A guide to MedPAC’s Part B vote this week

PhRMA  |  Blog Post

The ASP mechanism has been successful at moderating price growth over time, and even CMS has noted multiple competitive factors are at work to keep prices stable.
http://catalyst.phrma.org/medicare-monday-a-guide-to-medpacs-part-b-vote-this-week

Patient Profile: Out-of-Pocket Cost Burden for Patients Treating HIV/AIDS

PhRMA  |  Blog Post

Visit the Access Better Coverage website for more on understanding health insurance and getting the information you need to choose the plan that is best for you and your family.
http://catalyst.phrma.org/patient-profile-out-of-pocket-cost-burden-for-patients-treating-hiv/aids

Prescription Drug Lifecycle Helps Health Care Spending Hit Record Low

PhRMA  |  Blog Post

Get updates on this subject and/or other relevant issues here. 
http://catalyst.phrma.org/prescription-drug-lifecycle-helps-health-care-spending-hit-record-low

HIV/AIDS: Decline in Death Rates

Chartpack  |  From Our Network

The death rate for AIDS in the United States decreased dramatically following the introduction of the highly active antiretroviral treatment (HAART). 
http://chartpack.phrma.org/2016-perspective/chapter-1/hiv/aids-decline-in-death-rates

Dr. William "Bill" Chin, M.D.

PhRMA  |  Biography

Chin was at Eli Lilly and Company, where he had worked for the last decade, most recently as senior vice president for Discovery Research and Clinical Investigation. 
https://www.phrma.org/biography/dr-william-bill-chin-m-d

RxE HCV in New Mexico

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-new-mexico

How drug importation schemes could increase U.S. law enforcement burdens

PhRMA  |  Blog Post

They report, “the current fentanyl crisis is multi-faceted and involves a global supply of fentanyl and related materials.
http://catalyst.phrma.org/how-drug-importation-schemes-could-increase-u.s.-law-enforcement-burdens

Medicines in Development for Heart Disease & Stroke 2015

PhRMA  |  Report

Heart disease has been the leading cause of death in the United States since 1921, but these numbers are declining.
https://www.phrma.org/report/medicines-in-development-for-heart-disease-and-stroke-2015-report

RxE HCV in New Hampshire

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-new-hampshire

RxE HCV in New York

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-new-york

Key U.S. Health Industries Outline Six-Point Plan for Improved Health and Economic Growth in Asia-Pacific Region

PhRMA  |  Press Release

I don’t know of any other intergovernmental organization of this nature where regulators have come together with the private sector to work on aligning regulatory systems in this way.” 
https://www.phrma.org/press-release/key-u-s-health-industries-outline-six-point-plan-for-improved-health-and-economic-growth-in-asia-pacific-region

Medicare Monday: What is IPAB, and why is it bad for patients?

PhRMA  |  Blog Post

Representatives Roe and Ruiz.
http://catalyst.phrma.org/medicare-monday-what-is-ipab-and-why-is-it-bad-for-patients

Matt Ellefson May Have Cancer, But Cancer Doesn’t Have Him

From Hope To Cures  |  From Our Network

In this video he shares his inspirational story of defying the odds and managing his disease to lead a happy and active life because of the progress made in cancer research.
http://www.fromhopetocures.org/video/matt-ellefson-may-have-cancer-but-cancer-doesn-t-have-him

You have reviewed the first 150 results out of 2649. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next